lilly retatrutide trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Lilly's triple agonist delivers up

Research has shown that taking different medications with the same mechanism of action can significantly increase the risk of side effects

At standard doses of 100 mcg or below, cortisol and prolactin elevations are generally minimal

"We were concerned about starting patients on the GLP-1s and not having the fulfillment ability three to six months down the line," Carroll said

A general baseline (eight to 12 cups of water each day) is a good starting point, though adding sodiumeither through food or a simple electrolyte mixhelps retain fluid and improves dizziness and chills, Perez says

Patients had been previously diagnosed with autoimmune hypothyroidism (initial N = 312) or CFS (initial N = 16)